Objective
Female breast cancer is the most diagnosed cancer worldwide. In 2020, the International Agency for Research on Cancer estimated more than 2.26 million new cases of breast cancer. Early detection is crucial to survival; recovery rates approach 90% when detected in early stages. National population-based cancer screening programmes in Europe currently implement 3 standard imaging modalities: mammography, ultrasound and MRI. The downsides of these screening methods include ionising radiation, high costs and high false positive rates in screening results.
Our multidisciplinary consortium of 16 partners from 10 countries aims to contribute to EU’s Mission on Cancer and Beating Cancer Plan by drastically improving the prevention, diagnosis and monitoring of breast cancer while reducing the burden on women and female patients and their families, health care professionals and others who are directly or indirectly affected by breast cancer.
ThermoBreast proposes a new solution for accurate, harmless and non-contact screening, equally applicable for all age groups and breast densities and capable of detecting pre-cancerous states. This risk-free screening technology, recently patented by the project coordinator ThermoMind LTD, can detect vascular anomalies and asymmetry, caused by cancerous growth. It combines innovative screening through multiple sensitive infrared sensors with advanced AI analysis of temporal dynamic thermal patterns. Through its patient-centred integrated diagnostics approach, this project converges intelligent computer vision, blood vessel extraction and tissue analysis with advanced information technology to deliver a medical class 1 device that will be validated in an international multicentre clinical study. To enhance stakeholder participation, ThermoBreast involves end users, SSH experts and a patient organisation in the co-creation of the new screening solution and assesses its health and socio-economic benefits as well as its cost effectiveness. This action is part of the Cancer Mission cluster of projects on ‘Prevention, including Screening’.
Fields of science
- natural sciencescomputer and information sciencesartificial intelligencecomputer vision
- medical and health sciencesclinical medicineoncologybreast cancer
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensors
- natural sciencesphysical sciencesacousticsultrasound
Keywords
Programme(s)
- HORIZON.2.1 - Health Main Programme
Funding Scheme
RIA - Research and Innovation actionCoordinator
Fassuta
Israel
See on map
Participants (14)
10623 Berlin
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
32000 Haifa
See on map
80333 Muenchen
See on map
9713 GZ Groningen
See on map
1050 Brussel
See on map
1000 Brussels
See on map
69710 Tel Aviv
See on map
94805 Villejuif
See on map
50009 Kaunas
See on map
52621 Ramat Gan
See on map
T12 YN60 Cork
See on map
69120 Heidelberg
See on map
2000 Maribor
See on map
10126 Torino
See on map
Partners (2)
8008 Zurich
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
77030 Houston
See on map